Found: 10
Select item for more details and to access through your institution.
Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1195, doi. 10.3390/jcm9041195
- By:
- Publication type:
- Article
Diffuse plane normolipaemic xanthomatosis as a manifestation of monoclonal gammopathy.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 4, p. 411, doi. 10.1111/bjh.16141
- By:
- Publication type:
- Article
Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 3, p. 475, doi. 10.1111/bjh.15122
- By:
- Publication type:
- Article
Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update.
- Published in:
- Drugs, 2018, v. 78, n. 1, p. 19, doi. 10.1007/s40265-017-0841-y
- By:
- Publication type:
- Article
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4334, doi. 10.3390/cancers15174334
- By:
- Publication type:
- Article
Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 3041, doi. 10.3390/cancers12103041
- By:
- Publication type:
- Article
High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.
- Published in:
- Cytometry. Part A, 2019, v. 95, n. 3, p. 279, doi. 10.1002/cyto.a.23693
- By:
- Publication type:
- Article
Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lenalidomide for the treatment of relapsed and refractory multiple myeloma.
- Published in:
- Cancer Management & Research, 2012, v. 4, p. 253, doi. 10.2147/CMAR.S27087
- By:
- Publication type:
- Article
Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019: A Randomized, Controlled Trial.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 2, p. 206, doi. 10.1093/infdis/jiac334
- By:
- Publication type:
- Article